These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8675029)

  • 81. Construction of FLAG and histidine tagging vectors for Schizosaccharomyces pombe.
    Huang Y; Hamada M; Patel J; Maraia RJ
    Yeast; 2001 Mar; 18(5):463-8. PubMed ID: 11255254
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.
    van Houten NE; Zwick MB; Menendez A; Scott JK
    Vaccine; 2006 May; 24(19):4188-200. PubMed ID: 16488517
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Addition of a short peptide ligand to the adenovirus fiber protein.
    Michael SI; Hong JS; Curiel DT; Engler JA
    Gene Ther; 1995 Nov; 2(9):660-8. PubMed ID: 8548556
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [The use of filamentous phage M13 in protein engineering].
    Il'ichev AA; Minenkova OO; Tat'kov SI; Karpyshev NN; Eroshkin AM; Ofitserov VI; Akimenko ZA; Petrenko VA; Sandakhchiev LS
    Mol Biol (Mosk); 1990; 24(2):530-5. PubMed ID: 2362594
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cross-linked filamentous phage as an affinity matrix.
    Smith GP; Petrenko VA; Matthews LJ
    J Immunol Methods; 1998 Jun; 215(1-2):151-61. PubMed ID: 9744757
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Multipurpose vectors for peptide expression on the M13 viral surface.
    Fowlkes DM; Adams MD; Fowler VA; Kay BK
    Biotechniques; 1992 Sep; 13(3):422-8. PubMed ID: 1389174
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nucleotide sequence of the DNA packaging and capsid synthesis genes of bacteriophage P2.
    Linderoth NA; Ziermann R; Haggård-Ljungquist E; Christie GE; Calendar R
    Nucleic Acids Res; 1991 Dec; 19(25):7207-14. PubMed ID: 1837355
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system.
    Abrams CC; King AM; Belsham GJ
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3089-98. PubMed ID: 8847514
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cloning in a bacteriophage lambda vector for the display of binding proteins on filamentous phage.
    Hogrefe HH; Amberg JR; Hay BN; Sorge JA; Shopes B
    Gene; 1993 Dec; 137(1):85-91. PubMed ID: 8282204
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Phage presentation.
    Hill HR; Stockley PG
    Mol Microbiol; 1996 May; 20(4):685-92. PubMed ID: 8793867
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Selection for protease inhibitors using bacteriophage display.
    Markland W; Roberts BL; Ladner RC
    Methods Enzymol; 1996; 267():28-51. PubMed ID: 8743308
    [No Abstract]   [Full Text] [Related]  

  • 92. Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.
    Ju Z; Sun W
    Drug Deliv; 2017 Nov; 24(1):1898-1908. PubMed ID: 29191048
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Filamentous Bacteriophage-A Powerful Carrier for Glioma Therapy.
    Wang Y; Sheng J; Chai J; Zhu C; Li X; Yang W; Cui R; Ge T
    Front Immunol; 2021; 12():729336. PubMed ID: 34566987
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Conformational mimicry through random constraints plus affinity selection.
    Zhong G
    Methods Mol Biol; 1998; 87():165-73. PubMed ID: 9523270
    [No Abstract]   [Full Text] [Related]  

  • 95. Targeted filamentous bacteriophages as therapeutic agents.
    Yacoby I; Benhar I
    Expert Opin Drug Deliv; 2008 Mar; 5(3):321-9. PubMed ID: 18318653
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The development of inovirus-associated vector vaccines using phage-display technologies.
    Stern Z; Stylianou DC; Kostrikis LG
    Expert Rev Vaccines; 2019 Sep; 18(9):913-920. PubMed ID: 31373843
    [No Abstract]   [Full Text] [Related]  

  • 97. A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins.
    Velappan N; Fisher HE; Pesavento E; Chasteen L; D'Angelo S; Kiss C; Longmire M; Pavlik P; Bradbury AR
    Nucleic Acids Res; 2010 Mar; 38(4):e22. PubMed ID: 19955231
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Alternative bacteriophage display systems.
    Castagnoli L; Zucconi A; Quondam M; Rossi M; Vaccaro P; Panni S; Paoluzi S; Santonico E; Dente L; Cesareni G
    Comb Chem High Throughput Screen; 2001 Apr; 4(2):121-33. PubMed ID: 11281829
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Viruses: incredible nanomachines. New advances with filamentous phages.
    Hemminga MA; Vos WL; Nazarov PV; Koehorst RB; Wolfs CJ; Spruijt RB; Stopar D
    Eur Biophys J; 2010 Mar; 39(4):541-50. PubMed ID: 19680644
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Development of 2A peptide-based strategies in the design of multicistronic vectors.
    Szymczak AL; Vignali DA
    Expert Opin Biol Ther; 2005 May; 5(5):627-38. PubMed ID: 15934839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.